Dr. Betzaida Gonzalez Valentin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 528 Villa Fontana, Mayaguez, PR 00682 Phone: 787-379-7641 |
Astrid A Carrero Perez, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: Ave Condominio, Urb. Reparto Flamboyan, Mayaguez, PR 00680 Phone: 787-265-8349 Fax: 787-265-8349 |
Juan Bautista Cruz, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Carr 349 Km 2.7, Mayaguez, PR 00680 Phone: 787-834-6000 Fax: 787-831-6315 |
Ernesto Luis Cruz Sr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Carretbra #2 Ave, Hostos 440, Mayaguez, PR 00680 Phone: 787-833-7383 Fax: 787-833-7383 |
Alexsander Antonetti Negron, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 410 Ave Hostos Ste 2, Mayaguez, PR 00682 Phone: 787-743-3038 |
News Archive
Patients admitted to a hospital with major trauma and treated with the steroid hydrocortisone were less likely to be diagnosed with hospital-acquired pneumonia than patients who received placebo, according to a study in the March 23/30 issue of JAMA.
A post-graduate student from The University of Manchester's School of Psychological Sciences is investigating the theory that children with imaginary companions are quicker to develop language skills and retain knowledge.
Quick-Med Technologies, Inc. announced today that the Food and Drug Administration has issued Guidance to support the classification of the Company's NIMBUSĀ® barrier gauze wound dressings as Class II medical devices.
An intervention for adolescents aimed at improving the quality of treatment for depression is effective at reducing depression, according to a study in the January 19 issue of JAMA.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced updated data from its Phase 2 clinical trial of NeuVax at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 8 days ago